mgrc
Group enters into strategic cooperation for projects in the medical and biotechnology fields PETALING JAYA, Malaysia, Jan 9, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce a strategic cooperation with SIRIM Berhad, to explore the commercialisation of joint research and development (R&D) projects in the medical and biotechnology fields. SIRIM Berhad is wholly owned by the Malaysian Government, and is focused on R&D, standardisation and quality. The organisation acts as a catalyst ...
ACN Newswire
Group explores framework to roll out genetic screening services with partners in the Middle East United Arab Emirates (UAE), Oct 26, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced the signing of a Strategic Collaboration Agreement (SCA) outlining partnerships to market and distribute the Group's Dtect(R) range of genetic screening services in the United Arab Emirates (UAE). Other than Malaysian Genomics, the SCA involves American Spine Center (ASC), a Dubai, UAE-based specialist in spin...
ACN Newswire
Group is collaborating with Thai partners to supply its products and services PETALING JAYA, Malaysia, Sept 23, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. The Group signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co. Ltd. to produce CAR T-cells for suppl...
ACN Newswire
Group's financial performance supported by higher margin and contribution from biopharmaceutical business PETALING JAYA, Malaysia, Aug 30, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. The Group recorded a p...
ACN Newswire
The Group acquires 51% of kidney dialysis operator to offer holistic management of kidney health for dialysis patients PETALING JAYA, Malaysia, June 23, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad. Aquahealth is establishing a kidney dialysis centre in Gombak, Selangor, with the license to operate the centre owned by the Malaysia International Islamic Chamber of Commerc...
ACN Newswire
Bursa Securities waives need for Group to submit regularisation plan PETALING JAYA, Malaysia, June 13, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022. This followed the decision by Bursa Securities Malaysia Berhad to grant the Group a waiver in submitting a regularisation plan after being classified as an affected listed corporation pursuant to Rule 8.03A of the Listing Requirements...
ACN Newswire
Company assists by chipping in to donation drive for orphans and the underprivileged PETALING JAYA, Malaysia, Apr 28, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan 2022 programme through a monetary donation to help those in need. The Ihya Ramadhan 2022 programme will be held in several locations throughout the country and involves the breaking of fast and the giving of monetary aid to orphans and the underprivileged. Encik Azri Azerai, Ex...
ACN Newswire
- Bintai Kinden acquires 5.03% stake in MGRC- Newly redesignated Executive Director, Azri Azerai, to spearhead both companies' growth strategies PETALING JAYA, MALAYSIA, Feb 17, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new substantial shareholder, Bintai Kinden Corporation Berhad ("Bintai Kinden"), a specialist in mechanical and electrical engineering services to the construction sector, in the Group. Bintai Kinden now has an effective shareholding of 5.0...
ACN Newswire
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら